Public annual accounts

BIOFRESH BELGIUM financials

Name: BIOFRESH BELGIUM financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for BIOFRESH BELGIUM, with comparable measures and links to available source documents.

Company overview

Registry number

0438873629

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for BIOFRESH BELGIUM

2025 versus 2024

Operating line: €112,345,473
EBITDA: €4,024,411
Total assets: €26,097,530
Equity: €15,673,459

EBITDA margin +3.6% · Equity ratio +60.1%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Revenue	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€112,345,473	€4,024,411	€26,097,530	€15,673,459	-
202431 Dec 2024	€107,898,350	€3,923,073	€25,717,376	€13,801,496	-

Revenue line derived from reported turnover.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report